The Amgen Irish Open has been confirmed in a September date at The K Club as part of the DP World Tour’s 2025 schedule.

Vaccinex has global commercial and development rights to pepinemab and is the sponsor of the KEYNOTE-B84 study which is being performed in collaboration with Merck Sharp & Dohme Corp, a subsidiary of ...

Michael Hay, senior analyst at BioMedTracker, Sagient Research Systems, San Diego, USA, highlights the approval ... and romiplostim (Nplate; Amgen). Three of these products experienced regulatory ...

At 10:47 pm in India (12:17 pm in New York, USA), the DJIA index was down 130.1 points ... (down 2.2 per cent), IBM (down 1.8 ...

TEZSPIRE demonstrated a statistically significant and clinically meaningful reduction in nasal polyp size and reduced nasal congestion compared to placebo ...

Austrian and Turkish Opens return to DP World Tours 2025 schedule, as does the Nedbank Golf Challenge; Hero Cup added as team ...

The article continued: According to Morgan Stanley, the global market for blockbuster obesity drugs could increase by more than 15x over the next five years, as their benefits expand beyond weight ...

The "CC Chemokine Receptor Type 5 Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The CC ...

Markets struggling which way to look will be dizzy again in an event-strewn Wednesday but the spotlight first thing drops on ...

Eli Lilly and its investors this past week learned a hard lesson: The sky is no longer the limit when it comes to sales of its blockbuster glucagon-like peptide 1 (GLP-1) drugs for diabetes and ...

Quarter Highlights Include Key Additions to Management Team and Extension of Cash Runway into 2027 with $31M Raise via ATM Facility Company Reiterates Full-year Financial Guidance; On Track to Achieve ...

2 Division of Preventive and Behavioral Medicine, University of Massachusetts School of Medicine, Worcester, Massachusetts, USA 3 Division of Clinical Immunology ... Funding The study was supported in ...